Minimal antibody response in Imbokodo compels change of course for HIV vaccine research
Biktarvy combination pill may be most effective option for people with HIV and hepatitis B
Educating police on harm reduction can help to prevent HIV and fatal overdoses
Smart new single-cell assay shines a light on the HIV reservoir
PrEP inequities have worsened in the US over the last decade, both racially and regionally
Six-country study shows dolutegravir-based treatment is highly effective in children and adolescents
Gaps in U=U awareness globally: healthcare providers need to do more to get the message out
Weight gain on treatment: more evidence that TAF plus dolutegravir leads to greater gains
Widespread PrEP use is not leading to more hepatitis C transmission among gay and bisexual men
